लोड हो रहा है...
Racial Disparities in the Utilization of Novel Agents for Front-line Treatment of Multiple Myeloma
BACKGROUND: Treatment with novel agents has become the standard-of-care for newly diagnosed multiple myeloma, but members of racial and ethnic minority groups receive these agents at a lower rate than their peers. Researchers have largely attributed this finding to the higher costs of these drugs in...
में बचाया:
| में प्रकाशित: | Clin Lymphoma Myeloma Leuk |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247682/ https://ncbi.nlm.nih.gov/pubmed/32522440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2020.04.018 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|